Instruction for use: Fenoterol

Active substance: Fenoterol

ATX Code R03AC04 Fenoterol

Pharmacotherapeutic group:

Tocolytics

Beta-adrenergic agonist

The nosological classification (ICD-10)

J45 Asthma

Asthma physical effort, status asthmaticus, Bronchial asthma, Asthma lung flow, Bronchial asthma with obstruction of sputum discharge, Bronchial asthma heavy currents, Bronchial asthma physical effort, hypersecretory asthma, Hormone-dependent form of bronchial asthma, Relief of asthma attacks in bronchial asthma, Non-allergic asthma, nocturnal asthma, Exacerbation of asthma, Asthma attacks, Endogenous forms of asthma, Night asthma, Cough with bronchial asthma

O20.0 Threatened abortion

Abortion threatening, threatening miscarriage, Spastic conditions with the risk of abortion, Threatened miscarriage in the first trimester of pregnancy, The threat of miscarriage, threatened abortion, The threat of miscarriage, Threatened spontaneous miscarriage

O60 Premature birth

Pregnancy prematurity, The birth premature, Preterm labor pains, Premature contractions prehospital, Immobilization of the uterus before the cesarean section, Immobilization of the uterus, Acute tocolysis, Threatening premature labor, Premature discharge of water, Preventing premature births, The threat of premature birth

Composition

1 tablet contains 5 mg of fenoterol; in bottles of 100 pcs., in a carton one bottle.

Pharmacological Properties
Pharmachologic effect

bronchodilatory, tocolytic.

By selectively stimulating beta2-adrenergic receptors, it reduces contractile activity and lowers the tone of the uterus. Dilates the bronchi and blood vessels.

Indications

Threatening premature labor, uterine hypertonus, bronchial asthma, chronic bronchitis, spastic.

Contraindications

Hypersensitivity, glaucoma, unbalanced diabetes, hyperthyroidism, cardiovascular disease, bleeding with placenta previa, placental abruption, birth canal infection, fetal malformations.

Side effects

Tremor, headache, anxiety, sleep disturbances, palpitations, hypokalemia, increased blood sugar, and allergic reactions.

Interaction

Effect increase sympathomimetic.

Dosing and Administration

Inside - Table 1-2. 4 times a day (not to exceed 8 tablets. Per day).

Precautionary measures

Patients older can cause urinary retention. Do not appoint simultaneously with potassium-containing agents dihydrotachysterol, mineralocorticoid. Caution is required when used with corticosteroids.

Storage conditions

In a dry, dark place.

Keep out of the reach of children.

The shelf life

3 years.

Do not use beyond the expiration date printed on the package.